The Valley Desk

NCT04437511 · Interventional trial

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Overall registry status Active not recruiting

Phase 3

Conditions Alzheimer Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov